ALT vs OXY
Altimmune Inc (ALT) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
OXY (OXY) common stock.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
OXY does not have a complete income-statement cache yet.
ALT currently screens at market cap $527.0M. OXY currently screens at market cap $0.
Not investment advice. Open the ALT and OXY stock pages for the full models.
Not investment advice.